NCT04058548View on ClinicalTrials.gov

Clinical Utility of the 1-minute Sit to Stand Test as a Measure of Submaximal Exercise Tolerance in Patients With Cystic Fibrosis During Acute Pulmonary Exacerbation

NACompletedINTERVENTIONAL
Enrollment

27

Participants

Timeline

Start Date

September 5, 2019

Primary Completion Date

May 12, 2021

Study Completion Date

May 12, 2021

Conditions
Cystic Fibrosis
Interventions
DIAGNOSTIC_TEST

Sit to stand test

Participants will complete a sit to stand test in addition to a 6 minute walk test

Trial Locations (1)

02115

Boston Children's Hospital, Boston

All Listed Sponsors
lead

Boston Children's Hospital

OTHER

NCT04058548 - Clinical Utility of the 1-minute Sit to Stand Test as a Measure of Submaximal Exercise Tolerance in Patients With Cystic Fibrosis During Acute Pulmonary Exacerbation | Biotech Hunter | Biotech Hunter